Exicure share price today

(XCUR)

Exicure share price is $18.67 & ₹1,586.50 as on 21 Dec 2024, 2.30 'hrs' IST

$18.67

▲

2.93

(18.61%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Exicure share price in Dollar and Rupees. Guide to invest in Exicure from India. Also see the sentimental analysis on Indian investors investing in Exicure. Get details on the Indian mutual funds that are investing in Exicure. Get Analyst recommendations and forecasts along with all the Exicure's financials.

Exicure share price movements

Today's Low: $16.57
Today's High: $19.46
$18.67
11.25%
Downside
Day's Volatility :14.85%
Upside
4.06%
52 Weeks Low: $1.44
52 Weeks High: $36.00
$18.67
92.29%
Downside
52 Weeks Volatility :96.0%
Upside
48.14%

Exicure Returns

Period	Exicure Inc	Index (Russel 2000)
3 Months	363.28%	0.0%
6 Months	1036.34%	0.0%
1 Year	495.53%	0.0%
3 Years	-44.46%	-19.7%

Exicure Key Statistics

in dollars & INR

Previous Close	$15.74
Open	$16.91
Today's High	$19.46
Today's Low	$16.57
Market Capitalization	$41.0M
Today's Volume	$221.7K
52 Week High	$36.0
52 Week Low	$1.44
Revenue TTM	$500.0K
EBITDA	$-5.8M
Earnings Per Share (EPS)	$-2.02
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-144.41%

How to invest in Exicure from India?

It is very easy for Indian residents to invest directly in Exicure from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Exicure stock in both Indian Rupees (INR) and US Dollars (USD). Search for Exicure or XCUR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Exicure or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Exicure shares which would translate to 0.046 fractional shares of Exicure as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Exicure, in just a few clicks!

Returns in Exicure for Indian investors in Rupees

Investment Value

₹1,00,000

Exicure investment value today

Current value as on today

₹5,96,782

Returns

₹4,96,782

(+496.78%)

Returns from Exicure Stock

₹4,94,586 (+494.59%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Exicure

1412.5%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Exicure from India has grown in the last 30 days as on Dec 21, 2024. 1412.5% more purchase transactions for Exicure in the last 30 days versus the previous period.

624%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Exicure on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 624% more investors are searching Exicure in the last 30 days versus the previous period.

Global Institutional Holdings in Exicure

The Carlyle Group Inc
2.16%
HRT FINANCIAL LLC
0.56%
Northwestern University
0.40%
UBS Group AG
0.37%
Tower Research Capital LLC
0.05%
BlackRock Inc
0.04%

Analyst Recommendation on Exicure

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Exicure(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Exicure

What analysts predicted

Downside of 89.29%

Current:

$18.67

Target:

$2.00

Insights on Exicure

Price Movement
In the last 3 months, XCUR stock has moved up by 341.4%
Decreasing Revenue
Revenue is down for the last 3 quarters, 21.77M → 500.0K (in $), with an average decrease of 84.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -600.0K → -1.09M (in $), with an average decrease of 81.8% per quarter
XCUR vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 71.6%

Exicure Technicals Summary

Sell

Neutral

Buy

Exicure is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Exicure Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Exicure Inc	71.92%	1036.34%	495.53%	-44.46%	-95.49%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Exicure Inc	0.19	NA	NA	0.0	-1.44	-0.26	NA	1.75
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Exicure Inc	Sell	$41.0M	-95.49%	0.19	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Exicure

exicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. our 3-dimensional, spherical nucleic acid (sna™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. our lead programs address diseases from inflammatory disorders to oncology. sna constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. sna constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. moreover, snas can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.

Organization	Exicure
Employees	5
CEO	Mr. Paul Kang
Industry	Miscellaneous Commercial Services

Management People of Exicure

Name	Title
Mr. Paul Kang	CEO, President & Director
Ms. Jiyoung Hwang	CFO, Secretary & Director
Mr. Joshua Miller	Chief Accounting Officer

Important FAQs about investing in Exicure from India :

What is Exicure share price today?

Exicure share price today stands at $18.67, Open: $16.91 ; Previous Close: $15.74 ; High: $19.46 ; Low: $16.57 ; 52 Week High: $36.00 ; 52 Week Low: $1.44. The stock opens at $16.91, after a previous close of $15.74. The stock reached a daily high of $19.46 and a low of $16.57, with a 52-week high of $36.00 and a 52-week low of $1.44.

Can Indians buy Exicure shares?

Yes, Indians can invest in the Exicure (XCUR) from India.

With INDmoney, you can buy Exicure at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Exicure at zero transaction cost.

How can I buy Exicure shares from India?

It is very easy to buy Exicure from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Exicure be purchased?

Yes, you can buy fractional shares of Exicure with INDmoney app.

What are the documents required to start investing in Exicure stocks?

To start investing in Exicure, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.